Journal profile · Pharmacology & Pharmacy
FUNDAMENTAL & CLINICAL PHARMACOLOGY
ISSN 0767-3981 · eISSN 1472-8206 · Wiley-Blackwell Publishing Ltd · ENGLAND · Bimonthly · Founded 1987
FUNDAMENTAL & CLINICAL PHARMACOLOGY: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.65; hybrid open access; APC about USD 3,300; median 165 days to acceptance (74 articles, last 24 months); community-reported acceptance: fairly easy; 87 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
FUNDAMENTAL & CLINICAL PHARMACOLOGY is published by Wiley-Blackwell Publishing Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research and Nitric Oxide and Endothelin Effects, together about 21.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Fundamental & Clinical Pharmacology publishes reports describing important and novel developments in fundamental as well as clinical research relevant to drug therapy. Original articles, short communications and reviews are published on all aspects of experimental and clinical pharmacology including: Antimicrobial, Antiviral Agents Autonomic Pharmacology Cardiovascular Pharmacology Cellular Pharmacology Clinical Trials Endocrinopharmacology Gene Therapy Inflammation, Immunopharmacology Lipids, Atherosclerosis Liver and Gastrointestinal Tract Pharmacology Metabolism, Pharmacokinetics Neuropharmacology Neuropsychopharmacology Oncopharmacology Pediatric Pharmacology Development Pharmacoepidemiology Pharmacogenetics, Pharmacogenomics Pharmacokinetics Pulmonary Pharmacology Receptors, Signal Transduction Renal Pharmacology Thrombosis and Hemostasis. We do not publish Original articles or reviews reporting pharmacological activities of compounds derived from plant extracts and/or used in traditional medicine; Studies reporting pharmacological activities of novel compounds if no proper controls are performed; Single dose/concentration studies and those measuring only one endpoint; Case reports in clinical pharmacology; Descriptive pharmacovigilance studies. Abstracting and Indexing Information Abstracts in Anthropology (Sage) Abstracts on Hygiene & Communicable Diseases (CABI) Academic Search (EBSCO Publishing) Academic Search Alumni Edition (EBSCO Publishing) Academic Search Premier (EBSCO Publishing) BIOBASE: Current Awareness in Biological Sciences (Elsevier) Biological Abstracts (Clarivate Analytics) BIOSIS Previews (Clarivate Analytics) Botanical Pesticides (CABI) CAB Abstracts® (CABI) CAS: Chemical Abstracts Service (ACS) Chemistry Server Reaction Center (Clarivate Analytics) ChemPrep (Clarivate Analytics) Crop Physiology Abstracts (CABI) Current Chemical Reactions (Clarivate Analytics) Current Contents: Clinical Medicine (Clarivate Analytics) Current Index to Statistics (ASA/IMS) Dairy Science Abstracts (CABI) Embase (Elsevier) Global Health (CABI) HEED: Health Economic Evaluations Database (Wiley-Blackwell) Horticultural Science Abstracts (CABI) Index Chemicus (Clarivate Analytics) Journal Citation Reports/Science Edition (Clarivate Analytics) MEDLINE/PubMed (NLM) Nutrition Abstracts & Reviews Series A: Human & Experimental (CABI) Protozoological Abstracts (CABI) PubMed Dietary Supplement Subset (NLM) Reaction Citation Index (Clarivate Analytics) Review o
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Luc ZimmerPublisher website
Editorial board by country: none in mainland China; most named France 11 (11 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology7.6%
- Neuroscience and Neuropharmacology ResearchNeuroscience7.3%
- Nitric Oxide and Endothelin EffectsMedicine6.7%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology6.2%
- Cardiac electrophysiology and arrhythmiasMedicine5.9%
- Neuropeptides and Animal PhysiologyNeuroscience5%
- Drug Transport and Resistance MechanismsMedicine4.9%
- Pain Mechanisms and TreatmentsMedicine4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.65LetPub ·
- Impact factor (publisher)
- 2.7Publisher website ·
- Impact factor (publisher) 2025
- 2.7Publisher website ·
- CiteScore 2026-06
- 5.6LetPub ·
- CiteScore (publisher)
- 5.6Publisher website ·
- CiteScore (publisher) 2025
- 5.6Publisher website ·
- SJR 2026-06
- 0.67LetPub ·
- SNIP 2026-06
- 0.72LetPub ·
- h-index
- 64LetPub ·
- h-index
- 103OpenAlex ·
- i10-index
- 1,593OpenAlex ·
- 2-year mean citedness
- 1.87OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 23.79%LetPub ·
Volume
- Articles per year
- 51LetPub ·
- Articles per year (publisher) 2025
- 60Publisher website ·
- Downloads per year (publisher) 2025
- 190,508Publisher website ·
Articles by year OpenAlex count · 3,672 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 48 | 26 | 13 |
| 2025 | 87 | 52 | 136 |
| 2024 | 80 | 45 | 254 |
| 2023 | 118 | 61 | 829 |
| 2022 | 122 | 21 | 1,137 |
| 2021 | 112 | 19 | 1,145 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
165 daysMedian, submission to acceptance · P25–P75 112 days – 256 days
- Acceptance to online
- median 17 days (74 articles)
- Submission to online
- median 192 days
- Sample
- 74 articles with submission and acceptance dates (125 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 14%Publisher website ·
- Acceptance rate (publisher) 2025
- 14%Publisher website ·
- Submission to first decision
- 3 daysPublisher website ·
- Submission to first decision 2025
- 3 daysPublisher website ·
- Submission to acceptance 2025
- 157 daysPublisher website ·
- Acceptance to publication 2025
- 18 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,300 / EUR 2,790 / GBP 2,220 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Keywords
- 3–6
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required, 3
Article types accepted10, with length limits
- case reportPlease kindly note FCP no longer publishes Case Report articles. Article Types Description Word Limit Abstract Tables/figures References Original Articles Repor…Length not stated
- editorialPlease kindly note FCP no longer publishes Case Report articles. Article Types Description Word Limit Abstract Tables/figures References Original Articles Repor…Length not stated
- hypothesisPlease kindly note FCP no longer publishes Case Report articles. Article Types Description Word Limit Abstract Tables/figures References Original Articles Repor…Length not stated
- meta-analysisPlease kindly note FCP no longer publishes Case Report articles. Article Types Description Word Limit Abstract Tables/figures References Original Articles Repor…Length not stated
- original articlePlease kindly note FCP no longer publishes Case Report articles. Article Types Description Word Limit Abstract Tables/figures References Original Articles Repor…main text ≤ 5,000 words
- perspectivePlease kindly note FCP no longer publishes Case Report articles. Article Types Description Word Limit Abstract Tables/figures References Original Articles Repor…Length not stated
- reviewPlease kindly note FCP no longer publishes Case Report articles. Article Types Description Word Limit Abstract Tables/figures References Original Articles Repor…Length not stated
- review articlePlease kindly note FCP no longer publishes Case Report articles. Article Types Description Word Limit Abstract Tables/figures References Original Articles Repor…Length not stated
- short communicationPlease kindly note FCP no longer publishes Case Report articles. Article Types Description Word Limit Abstract Tables/figures References Original Articles Repor…Length not stated
- systematic reviewPlease kindly note FCP no longer publishes Case Report articles. Article Types Description Word Limit Abstract Tables/figures References Original Articles Repor…Length not stated
Policy excerpts from the journal's websitePeer review, Trial registration / reporting guidelines
- Peer review 4. PEER REVIEW
Peer Review Policy This journal operates under a single-blind peer review model. Papers will only be sent to review if the Editors-in-Chief determines that the paper meets the appropriate quality and relevance requirements. In-house submissions, i.e. papers authored by Editorial Board members will be sent to reviewers unaffiliated with the author or institution and monitored carefully to ensure th…
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting guidelines
Reporting guidelines promote clear reporting of methods and results to allow critical appraisal of the manuscript. We ask that all manuscripts be written in accordance with the appropriate reporting guideline. Please submit as supplemental material the appropriate reporting guideline checklist showing on which page of your manuscript each checklist item appears.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1987
- ISSN
- 0767-3981
- Electronic ISSN
- 1472-8206
- Society / sponsor
- Société Française de Pharmacologie et de Thérapeutique
- Latest issue on the website
- Volume 40, Issue 5 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about FUNDAMENTAL & CLINICAL PHARMACOLOGY
What CAS zone is FUNDAMENTAL & CLINICAL PHARMACOLOGY in?
In the 2025 upgraded edition of the CAS Journal Ranking, FUNDAMENTAL & CLINICAL PHARMACOLOGY is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of FUNDAMENTAL & CLINICAL PHARMACOLOGY?
The latest impact factor listed by LetPub is 2.65; CiteScore 5.6, h-index 103.
How long does peer review take at FUNDAMENTAL & CLINICAL PHARMACOLOGY?
Based on the dates recorded on 74 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 165 days (interquartile range 112–256 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 14% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of FUNDAMENTAL & CLINICAL PHARMACOLOGY?
According to the journal's author guidelines: Keywords: 3–6; Reference style: AMA; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required, 3. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of FUNDAMENTAL & CLINICAL PHARMACOLOGY based?
Of the 11 board members whose country the journal's board page names, none are in mainland China; the countries named most often are France (11). Counted from the institutions listed on the board page; for reference only.
Which databases index FUNDAMENTAL & CLINICAL PHARMACOLOGY?
According to LetPub and DOAJ records, FUNDAMENTAL & CLINICAL PHARMACOLOGY is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is FUNDAMENTAL & CLINICAL PHARMACOLOGY open access, and what is the APC?
FUNDAMENTAL & CLINICAL PHARMACOLOGY is a hybrid journal. For open-access publication: APC about USD 3,300.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .